TENOR CAPITAL MANAGEMENT Co., L.P.
Position in SLXN — Silexion Therapeutics Corp
CIK 1346554
NEW YORK, NY
Position in SLXN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.899%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TENOR CAPITAL MANAGEMENT Co., L.P. holds $0 across 7 Biotechnology names. SLXN ranks #6 .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JSPR |
Jasper Therapeutics, Inc.
|
250,000 | $0 | |
| 2 | ICU |
SeaStar Medical Holding Corp
|
40,000 | $0 | |
| 3 | TVGN |
Tevogen Inc.
|
125,000 | $0 | |
| 4 | VRXA |
Veraxa Biotech Holding AG
|
150,000 | $0 | |
| 5 | PBM |
Psyence Biomedical Ltd.
|
150,000 | $0 | |
| 6 | SLXN |
Silexion Therapeutics Corp
This page
|
50,000 | $0 | |
| 7 | DRTS |
Alpha Tau Medical Ltd.
|
150,000 | $0 |
All Filings in SLXN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 SLXNW | — | 50,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 SLXNW | — | 50,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 SLXNW | — | 50,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 SLXNW | — | 50,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 SLXNW | — | 50,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 SLXNW | — | 50,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 SLXNW | — | 50,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 SLXNW | — | 50,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||